Saturday, July 18, 2015

Alzheimer's Drug Is a Big Bet for Lilly

Researchers will provide clues about whether Lilly’s risky bet on an experimental drug for Alzheimer’s disease ultimately pays off—for patients and for the company’s bottom line.

from WSJ.com: US Business http://ift.tt/1OdDTNH
via IFTTT

No comments:

Post a Comment